EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer

[MEDPAGE TODAY]( Oncology Update Friday, June 21, 2024 [EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer]( [Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL]( [Novel Anti-CD38 Drug Shows Promise for Immune Thrombocytopenia]( [Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC]( [ALK Inhibitor Shows Promise in Rare, Progressive Tumor Types]( ADVERTISEMENT Exclusives & Features [FDA Warns Yet Another Birth Tissue Company]( [BMJ Paper at Center of COVID Vax Deaths Controversy Gets Expression of Concern]( [Texas Doc Accused of Illegally Accessing Child Health Records]( Industry Clinic Ad Insights [What Will It Take to Deliver Both Health & Care in Oncology?]( [Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry.]( BACKGROUND: There are no studies assessing the evolution and patterns of genetic studies performed at diagnosis in acute myeloid leukemia (AML) patients. Such studies could help to identify potential... [READ MORE]( [Five-year outcomes of fractionated stereotactic body radiotherapy for oligometastatic prostate cancer from the TRANSFORM phase II trial.]( Metastasis-directed therapy (MDT) for oligometastatic prostate cancer (PCa), including stereotactic body radiotherapy (SBRT), has shown promise but is still considered investigational. This is the... [READ MORE]( [Inhibition of the Rho/MRTF pathway improves the response of BRAF-resistant melanoma to PD1/PDL1 blockade.]( Metastatic cutaneous melanoma is a fatal skin cancer. Resistance to targeted and immune therapies limits the benefits of current treatments. Identifying and adding anti-resistance agents to current... [READ MORE]( [Minimally Invasive Esophagectomy Provides Better Short- and Long-Term Outcomes Than Open Esophagectomy in Locally Advanced Esophageal Cancer.]( BACKGROUND: Minimally invasive esophagectomy (MIE) has been increasingly performed for locally advanced esophageal cancer in place of open transthoracic esophagectomy (OE). This study explored the... [READ MORE]( [Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease.]( BACKGROUND: Resection of perihilar cholangiocarcinoma (pCCA) is a complex procedure with a high risk of postoperative mortality and early disease recurrence. The objective of this study was to... [READ MORE]( [A Property of Everyday Health group]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2024-06-21&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011